169323 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids; Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors Interleukin
METHODS AND KITS FOR PREDICTING THE RISK OF HAVING A CARDIOVASCULAR EVENT IN A SUBJECT
#602IL-17 antagonist antibodies
#603Biomarkers
#604In-vitro process for the quick determination of a patient's status relating to infection with
#605Human antibody specific for IL-1alpha
#606SYSTEM, AN APPARATUS AND A COMPUTER PROGRAM PRODUCT FOR OBTAINING AN INFORMATION RELATED TO EOSINOPHILIC AIRWAY INFLAMMATION
#607Predicting risk of major adverse cardiac events
#608Method of treating sigma 1 receptor-expressing tumors with interleukin 24
#609Humanized anti-IL-10 antibodies for the treatment of systemic lupus erythematosus (SLE)
#610Kit for monitoring immune status after transplant and method for monitoring immune status using same
#611Method for Stimulating T Cell and Use Thereof
#612Number of IL4 and/or IL13 secreting T-cells as a biomarker for allergic diseases
#613PROSTAGLANDIN E2 DUAL VARIABLE DOMAIN IMMUNOGLOBULINS AND USES THEREOF
#614System for detecting infection in synovial fluid
#615Methods of treating inflammatory diseases using antibodies that bind both IL-17A and IL-17F
#616Methods of treating chronic disorders with complement inhibitors
#617NON-INVASIVE METHODS FOR ASSESSING OOCYTE QUALITY FOR IN VITRO FERTILIZATION
#618DIAGNOSIS AND TREATMENT OF VIRAL DISEASES
#619Biomarkers for Tuberculosis and HIV/AIDS
#620Compositions and Methods for the Systemic Treatment of Arthritis
#621Nucleic acid molecules encoding moonoclonal antibodies speceific for IL17F
#622MATERIALS AND METHODS FOR DETECTING AND/OR PREDICTING NECROTIZING ENTEROCOLITIS IN INFANTS
#623NEW TH-17 DIFFERENTIATION MARKERS FOR ROSACEA AND USES THEREOF
#624Soluble ST2 as a marker for risk of mortality in HIV-infected subjects
#625Disulphide bond-stabilized functional soluble MHC class II heterodimers
#626Methods of treating autoimmune diseases by administering monoclonal antibodies against human IL-12
#627MONOCLONAL ANTIBODY AGAINST INTERFERON-GAMMA (IFN-GAMMA) INDUCING FACTOR (IFIG, IL-18)
#628METHOD FOR DIAGNOSING AND TREATING FIBROMYALGIA
#629Method of isolating human antibodies
#630IL-1 ALPHA DUAL VARIABLE DOMAIN IMMUNOGLOBULINS AND USES THEREOF
#631Nucleic acids encoding interleukin-31 monoclonal antibody and uses thereof
#632Cytokine biomarkers as predictive biomarkers of clinical response for glatiramer acetate
#633Methods of treating a subject having heart failure
#634Biocompatible and bioabsorbable derivatized chitosan compositions
#635CARDIAC STEM CELL AND MYOCYTE SECRETED PARACRINE FACTORS AND USES THEREOF
#636Methods and compositions for enhancing immunoassays
#637Dual specific binding proteins directed against IL-1 and/or IL-17
#638Dual Specific Binding Proteins Directed Against TNF
#639TH17 DIFFERENTIATION MARKERS FOR ACNE AND USES THEREOF
#640Methods of determining efficacy of treatment in a subject having heart failure
#641METHOD OF TREATING MULTIPLE SCLEROSIS BY INTRATHECAL DEPLETION OF B CELLS AND BIOMARKERS TO SELECT PATIENTS WITH PROGRESSIVE MULTIPLE SCLEROSIS
#642Dual variable domain immunoglobulins and uses thereof
#643TH17 DIFFERENTIATION MARKERS FOR ACNE AND USES THEREOF
#644MICROFLUIDIC ASSAY DEVICES AND METHODS
#645IL-1 binding proteins
#646DUAL VARIABLE DOMAIN IMMUNOGLOBULINS AND USES THEREOF
#647DUAL VARIABLE DOMAIN IMMUNOGLOBULINS AND USES THEREOF
#648IL-1 binding proteins
#649IL-1 binding proteins
#650IL-1 binding proteins
#651Method for the treatment of acne by administering IL-1β antibody
#652ANTI-INFLAMMATORY FOOD PRODUCT
#653Method to screen for an activator of adipose-resident NK cells
#654Nucleic acids encoding a human monoclonal antibody that specifically binds to IL-1α
#655IL-12/p40 BINDING PROTEINS
#656Protection of cells from -RNA-induced degeneration and inhibitors for protecting cells
#657HUMAN MONOCLONAL ANTIBODIES AGAINST INTERLEUKIN 8 (IL-8)
#658IL-21 EPITOPE AND IL-21 LIGANDS
#659Methods for diagnosing degenerative joint disease
#660Methods of modulating cytokine activity; related reagents
#661Induced intercellular communication
#662Antibody to human IL-1 beta
#663Anti-IL-23 Antibodies
#664CYTOKINE PROFILES AS METHODS FOR DIAGNOSIS AND PROGNOSIS OF IRRITABLE BOWEL SYNDROME
#665METHODS FOR MODULATING IL-33 ACTIVITY
#666MARKERS FOR IMPAIRED BONE FRACTURE HEALING
#667IL-1 binding proteins
#668Method for increasing granulocyte number in a patient by administering superactive IL-33 fragments
#669MAMMALIAN CYTOKINES; RECEPTORS; RELATED REAGENTS AND METHODS
#670Lipocalin 2 as a biomarker for IL-17 inhibitor therapy efficacy
#671Methods for predicting risk of developing hypertension
#672METHODS FOR DIAGNOSING IRRITABLE BOWEL SYNDROME
#673Anti-IL-23 antibodies, compositions, methods and uses
#674Predicting mortality and detecting severe disease
#675Nucleic acids encoding anti-NR10 antibodies
#676ADJUVANTS THAT ACTIVATE ADAPTIVE IMMUNE SYSTEM BY STIMULATING NLRP3
#677IL-8 level as a determinant of responsivity of a cancer to treatment
#678METHODS AND KITS FOR PREDICTING THE RISK OF HAVING A CARDIOVASCULAR EVENT IN A SUBJECT
#679SOLID SUPPORT AND METHOD OF RECOVERING BIOLOGICAL MATERIAL THEREFROM
#680Methods for treatment of cardiovascular disease
#681Methods of Diagnosing and Treating an Inflammatory Response
#682USING A CYTOKINE SIGNATURE TO DIAGNOSE DISEASE OR INFECTION
#683METHODS FOR DIAGNOSIS AND PROGNOSIS OF INFLAMMATORY BOWEL DISEASE USING CYTOKINE PROFILES
#684Method for diagnosing Lyme disease using a cellular immunological test
#685Polynucleotides encoding antibodies that bind both IL-17A and IL-17F
#686Method for identifying biologically active oligonucleotides capable of modulating the immune system
#687Determination of the efficacy of an anti-mycobacterial vaccination
#688Method for screening drugs for suppressing inflammasome activity
#689Method for analyzing proteins contributing to autoimmune diseases, and method for testing for said diseases
#6901L1RL-1 as a cardiovascular disease marker and therapeutic target
#691Recombinant IL-9 Antibodies And Uses Thereof
#692Single Molecule Assays
#693Function homology screening
#694Methods and Compositions for Highly Sensitive Detection of Molecules
#695ANTIBODIES DIRECTED TO GPNMB AND USES THEREOF
#696Predicting risk of major adverse cardiac events
#697DEVICES AND METHODS FOR ANALYSIS OF SAMPLES WITH DEPLETION OF ANALYTE CONTENT
#698BIOMARKER
#699BIOMARKERS OF CANCER
#700METHODS OF DETERMINING EFFICACY OF TREATMENTS OF DISEASES OF THE BOWEL
#701MARKERS OF VULNERABILITY OF THE ATHEROSCLEROSIS PLAQUE
#702Multiplex Immune Effector Molecule Assay
#703THERAPEUTIC AGENT OF NON-ALLERGIC AIRWAY INFLAMMATION AND/OR NON-ALLERGIC HYPERRESPONSIVE AIRWAY
#704Methods of using IL-31 antagonists in diseases mediated by cutaneous lymphocyte antigen positive T cells
#705IL-I binding proteins
#706Methods and device for tuning multiplexed markers for disease assay
#707Soluble human ST-2 antibodies and assays
#708Compounds useful for multi-level specific targeting of cancer cells
#709SOLUBLE ST2 AS A MARKER FOR DISEASE
#710Antagonists of IL-23P19 for treatement of atopic dermatitis
#711BIOMARKERS
#712IL-6 DETECTION BASED EARLY DIAGNOSIS AND PREDICTION OF SYSTEMATIC INFLAMMATORY RESPONSE SYNDROME AND SEPSIS IN ASYMPTOMATIC PATIENTS
#713Interleukin-31 monoclonal antibody
#714Methods and biomarkers for the detection of dengue hemorrhagic fever
#715Polynucleotides encoding antibodies that bind both IL-17A and IL-17F
#716MOLECULAR MARKER FOR EVALUATING PATHOLOGICAL CONDITIONS AND TREATMENT OF MUSCULAR DYSTROPHY
#717Humanized anti-IL-10 antibodies for the treatment of systemic lupus erythematosus (SLE)
#718Humanized anti-IL 10 antibodies for the treatment of systemic lupus erythematosus (SLE)
#719PROCESS FOR THE MEASUREMENT OF THE POTENCY OF GLATIRAMER ACETATE
#720Anti-IL-23 antibodies
#721Methods predicting risk of an adverse clinical outcome
#722METHODS OF TREATMENT UTILIZIING BINDING PROTEINS OF THE INTERLEUKIN-21 RECEPTOR
#723B7-H4 fusion proteins and methods of use thereof
#724INDICATOR AGENT FOR NONINFLAMMATORY STRESS RESPONSE AND USE THEREOF
#725COMPOSITIONS AND METHODS FOR THE SYSTEMIC TREATMENT OF ARTHRITIS
#726Human monoclonal antibodies against CD25
#727DIAGNOSTIC BIOMARKER TO IDENTIFY WOMEN AT RISK FOR PRETERM DELIVERY
#728METHODS FOR MODULATING IL-33 ACTIVITY
#729MARKER FOR DIAGNOSIS OF ACTIVE MULTIPLE SCLEROSIS
#730METHODS OF TREATMENT USING AN ANTI IL B50 ANTIBODY
#731Methods and compositions for the inhibition of transplant rejection
#732Interleukin-1 Alpha Antibodies and Methods of Use
#733Methods of treating cancer with human monoclonal antibodies against interleukin 8
#734T-Bet Compositions and Methods of Use Thereof
#735Compositions and Methods for the Systemic Treatment of Arthritis
#736Cytokine biomarkers as predictive biomarkers of clinical response for Glatiramer acetate
#737TREATMENT OF ONCOSTATIN M RECEPTOR BETA MEDIATED HEART FAILURE
#738Biomarker for treating cancer patients
#739Recombinant IL-9 antibodies and uses thereof
#740Mammalian receptor proteins DCRS5; methods of treatment
#741Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles
#742PREDICTING RISK OF MAJOR ADVERSE CARDIAC EVENTS
#743Antibodies to signal transduction protein TAB2
#744Monocyte activation test better able to detect non-endotoxin pyrogenic contaminants in medical products
#745Method for Predicting the Responsiveness to an Anti-TNF Alpha Antibody Treatment
#746IDENTIFICATION, MONITORING AND TREATMENT OF INFECTIOUS DISEASE AND CHARACTERIZATION OF INFLAMMATORY CONDITIONS RELATED TO INFECTIOUS DISEASE USING GENE EXPRESSION PROFILES
#747Methods of identifying a subject as having heart failure
#748Dual variable domain immunoglobulins and uses thereof
#749IL-18 RECEPTOR AS A NOVEL TARGET OF REGULATORY T CELLS IN CANCER
#750Interleukin-1 Alpha Antibodies and Methods of Use
#751Phosphorylated NF45 Biomarkers, Antibodies And Methods Of Using Same
#752Interleukin-1 alpha antibodies and methods of use
#753Interleukin-1α antibodies and methods of use
#754Interleukin-1 alpha antibodies and methods of use
#755METHODS FOR GENERATING ANTI-IL-23 ANTIBODIES, COMPOSITIONS, METHODS AND USES
#756IL-17A/F HETEROLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF
#757Mutant interleukin-2 (IL-2) polypeptides
#758Methods for Diagnosing, Staging, Predicting Risk for Developing and Identifying Treatment Responders for Rheumatoid Arthritis
#759Multi-level specific targeting of cancer cells with IL-13
#760Methods for treatment of cardiovascular disease
#761IL-1 binding proteins
#762INFLAMMATORY BIOMARKERS FOR MONITORING DEPRESSIVE DISORDERS
#763Predicting mortality and detecting severe disease
#764Biomarker-based methods for formulating compositions that improve skin quality and reduce the visible signs of aging in skin for individuals in a selected population
#765Biomarker-Based Methods For Formulating Compositions That Improve Skin Quality And Reduce The Visible Signs Of Aging In Skin
#766Soluble human ST-2 antibodies and assays
#767Cardiac stem cell and myocyte secreted paracrine factors
#768Methods For Improving Skin Quality
#769Methods For Improving Skin Quality
#770Methods For Improving Skin Quality
#771IL1RL-1 as a cardiovascular disease marker and therapeutic target
#772Methods For Improving Skin Quality
#773Methods For Improving Skin Quality
#774Anti-IL-6 Receptor Antibody
#775Methods for assessing drug efficacy and response of patient to therapy
#776METHODS AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF AUTOIMMUNE DISEASE SECONDARY TO MULTIPLE SCLEROSIS
#777Anti-NR10 antibody and use thereof
#778METHODS OF MODULATING IL-22 AND IL-17
#779Methods of treating diseases which are mediated by cutaneous lymphocyte antigen positive cells
#780Process for the measurement of the potency of glatiramer acetate
#781Detection of intraamniotic infection
#782Aptamer against IL-17 and use thereof
#783Methods of determining efficacy of treatments of diseases of the bowel
#784CYTOKINE RECEPTOR MODULATORS AND USES THEREOF
#785METHODS FOR TREATING AND PREVENTING FIBROSIS
#786Mammalian receptor protein DCRS5; methods of treatment
#787ANTI-NR10 ANTIBODY AND USE THEREOF
#788USE OF IMMUNOREGULATORY NK CELL POPULATIONS FOR PREDICTING THE EFFICACY OF ANTI-IL-2R ANTIBODIES IN MULTIPLE SCLEROSIS PATIENTS
#789COPD diagnosis
#790Methods for up-regulating PAP1 in animals suffering from pancreatic disorders
#791PROCESS FOR THE PURIFICATION OF INTERLEUKIN-4 AND ITS MUTEINS
#792Interleukin-33 (IL-33) for the Diagnosis and Prognosis of Cardiovascular Disease
#793Methods for treating allergic airway inflammation, airway hypersensitivity, and eosinophilia
#794METHODS FOR DIAGNOSING DIABETES AND DETERMINING EFFECTIVENESS OF TREATMENTS
#795Method for screening inhibitors of interleukin-32 (IL-32)
#796INTERLEUKIN-17F ANTIBODIES AND OTHER IL-17F SIGNALING ANTAGONISTS AND USES THEREFOR
#797MARKER FOR DETECTION OF IL-17-PRODUCING HELPER T-CELL, AND METHOD FOR DETECTION OF IL-17-PRODUCING HELPER T-CELL
#798Highly sensitive biomarker panels
#799Cytokine production-inducing antibody
#800CHARACTERIZATION OF IL-17F AND IL-17R INTERACTIONS
#801Methods and Uses of Anti-IL-23 Antibodies
#802Organic Compounds
#803ASSAY
#804Antibodies that bind both IL-17A and IL-17F
#805Diagnostic Methods and Arrays for Use in the Same
#806Human monoclonal antibodies against interleukin 8 (IL-8)
#807Biomarkers for Septic Shock Patients
#808Mammalian receptor proteins DCRS5; method of treatment
#809Antibodies to human programmed death receptor PD-1
#810Methods of using IL-31 antagonists in diseases mediated by cutaneous lymphocyte antigen positive T cells
#811Method of treating inflammatory disease by inhibition of IL-17 production
#812INHIBITION OF IL-17 PRODUCTION
#813Method for assessing risk of heart failure
#814ASSAYS FOR DETERMINING EXPOSURE TO MULTIWALLED CARBON NANOTUBES
#815Minimally-invasive measurement of esophageal inflammation
#816MARKER FOR ARRHYTHMIA RISK
#817Methods and compositions for the treatment of sterile inflammation
#818Nucleic acids encoding murine IL-174
#819Monocyte activation test better able to detect non-endotoxin pyrogenic contaminants in medical products
#820Monocyte activation test better able to detect non-endotoxin pyrogenic contaminants in medical products
#821Pathway for Th-17 Cell Development and Methods Utilizing Same
#822IL-12/p40 binding proteins
#823IL-23 RECEPTOR ANTAGONISTS AND USES THEREOF
#824IRAK-1 AS REGULATOR OF DISEASES AND DISORDERS
#825Method for Analyzing Clinical Trial Results for Efficacy of a Therapy
#826Nanoelectronic-enzyme linked immunosorbent assay system and method
#827INTERLEUKIN 6 AND TUMOR NECROSIS FACTOR ALPHA AS BIOMARKERS OF JNK INHIBITION
#828Methods and Compositions for Diagnosing Urological Disorders
#829IL1RL-1 as a cardiovascular disease marker and therapeutic target
#830Methods of treating or diagnosing conditions associated with elevated IL-6 using anti-IL-6 antibodies or fragments
#831Kit comprising an antibody to interleukin 17 receptor-like protein
#832Stabilized bacterial formulation
#833SINGLE MOLECULE ASSAYS
#834Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles
#835Prostaglandin E2 dual variable domain immunoglobulins and uses thereof
#836Compositions and methods for the systemic treatment of arthritis
#837Methods of predicting steroid responsiveness with Il-1RII
#838Compositions and methods for the systemic treatment of arthritis
#839DIAGNOSIS OF PULMONARY AND/OR CARDIOVASCULAR DISEASE
#840IL-12/p40 binding proteins
#841Mutant interleukin-2 (IL-2) polypeptides
#842Hematopoietic cell phenotyping using circulating cell-free markers
#843Diagnosis of cardiovascular disease
#844BIOMARKER FOR ASSESSING RESPONSE TO CHYMASE TREATMENT
#845Method for detecting IL-16 activity and modulation of IL-16 activity based on rantes proxy protein levels
#846Dual variable domain immunoglobulins and uses thereof
#847TEST KIT FOR DETECTING PERIODONTAL DISEASE
#848INTERLEUKIN-33 (IL-33) FOR THE DIAGNOSIS AND PROGNOSIS OF CARDIOVASCULAR DISEASE
#849Interleukin-1α antibodies
#850Methods of treatment utilizing binding proteins of the interleukin-21 receptor
#851Methods for Screening Interleukin-6 (IL-6) Signal Transduction Inhibitors
#852METHODS OF TREATING DISEASES WHICH ARE MEDIATED BY CUTANEOUS LYMPHOCYTE ANTIGEN POSITIVE CELLS
#853Method of treatment using an anti-IL-B50 antibody
#854Assessing risk of disease progression in rheumatoid arthritis patients
#855Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof
#856Predicting risk of major adverse cardiac events
#857IL-6/IL-6R Fusion Protein
#858METHODS FOR MEASURING PRO-INFLAMMATORY SUBSTANCE LEVELS IN DIALYSIS SOLUTIONS AND DIALYSIS COMPONENTS
#859METHOD AND COMPOSITIONS FOR HIGHLY SENSITIVE DETECTION OF MOLECULES
#860Dual specificity antibodies and methods of making and using
#861Nucleic acids encoding receptor for IL-17 homologous polypeptides and therapeutic uses thereof
#862Interleukin-4 receptors
#863Method for Discovering Inhibitors of the Epstein-Barr Virus-Induced Gene 3 (EBI3) and Derivatives Thereof for the Treatment of Metastasizing Tumors and Allergic Asthma
#864Methods for monitoring IL-18
#865Method and kit for diagnosing acute myocardial infarction
#866Methods of Diagnosing and Treating an Inflammatory Response
#867Methods for diagnosis of cardiovascular disease
#868Transdiscal administration of specific inhibitors of pro-inflammatory cytokines
#869IL-13 production inhibitor
#870Anti-IL-23 antibodies, compositions, methods and uses
#871ASSAYS AND METHODS FOR EVALUATING MULTIMERIC COMPLEXES
#872Transdiscal administration of anti-TNFα antibodies and growth differentiation factors
#873INTERLEUKIN-17F ANTIBODIES AND OTHER IL-17F SIGNALING ANTAGONISTS AND USES THEREFOR
#874Methods for determining anti-TNF therapeutic response
#875Method for Detecting IL-16 Activity and Modulation of IL-16 Activity Based on Phosphorylated Stat-6 Proxy Levels
#876INTERLEUKIN-22 POLYPEPTIDES, NUCLEIC ACIDS ENCODING THE SAME AND METHODS FOR THE TREATMENT OF PANCREATIC DISORDERS
#877Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating thereto
#878Method for diagnosing cardiovascular diseases
#879Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders
#880Methods of predicting therapeutic response in atopic dermatitis to IL-31 antagonists
#881MARKER FOR ARRHYTHMIA RISK
#882DEVICES AND METHODS FOR ANALYSIS OF SAMPLES WITH DEPLETION OF ANALYTE CONTENT
#883Human monoclonal antibodies against CD25
#884Process for the measurement of the potency of glatiramer acetate
#885Cytokine receptor modulators and uses thereof
#886RECOMBINANT IL-9 ANTIBODIES AND USES THEREOF
#887Methods of Modulating Cytokine Activity; Related Reagents
#888IL-17 homologous polypeptides and therapeutic uses thereof
#889Indicator Agent for Noninflammatory Stress Response and Use Thereof
#890Antibodies that bind both IL-17A and IL-17F and methods of using the same
#891Mammalian receptor protein DCRS5; methods of treatment
#892Methods for monitoring patients with severe sepsis and septic shock and for selecting treatments for these patients
#893T-bet compositions and methods of use thereof
#894Method for diagnosing and treating acute joint injury
#895Anti-Inflammatory Signal Molecules and Exercise
#896Il-32 Modulators
#897SPECIFIC BINDING AGENTS FOR KSHV vIL-6 THAT NEUTRALIZE A BIOLOGICAL ACTIVITY
#898Therapeutic Strategy for Treating Autoimmune and Degenerative Diseases
#899METHODS AND COMPOSITIONS FOR MODULATING IL-17F/IL-17A BIOLOGICAL ACTIVITY
#900ANTAGONIZING INTERLEUKIN-21 RECEPTOR ACTIVITY